Replies to post #149549 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

CONCLUSION:

Sig-1R agonists have been used in the treatment of different neurodegenerative diseases, e.g. Alzheimer's and Parkinson's diseases (AD and PD) and amyotrophic lateral sclerosis. Utilization of Sig-1R agents early in AD and similar other diseases has remained an overlooked therapeutic opportunity.

https://www.ncbi.nlm.nih.gov/pubmed/28554311